Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more ...
San Antonio Spurs superstar Victor Wembanyama will likely miss the rest of the season because of deep vein thrombosis. What ...
Two Groundbreaking Studies on Fluid Management: Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge ...
Pulmonary hypertension, despite advances in treatment, still has a poor prognosis, which is often associated with right heart failure, and for which pulmonary arterial hypertension (PAH) is a severe ...
Daxor (DXR) announces new studies from Duke University Medical Center and Yale School of Medicine, presented at the Technology and Heart ...
Lungpacer Medical today announced positive results from a Phase 1 clinical study evaluating its neurostimulation technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results